Actualités et Analyses

Lonza and the next wave of healthcare solutions

May 5, 2026

Temps de lecture: 3:57 mins

Walter Scott’s John Rae assesses outsourced drugs manufacturer Lonza’s role in the healthcare ecosystem.

Key points:

Lonza’s role in the healthcare space is simliar to that of chip manufacturers in the semiconductor supply chain.
The company has high customer retention which creates resilient revenues.
It is investing heavily to support growth, including building manufacturing capacity in the US.
Walter Scott sees several quality healthcare businesses with high degrees of profitability, cash generation and low levels of debt.

3305309 Exp: 7 août 2026

Chart of the week | Macroéconomique

Steady hiring, fewer layoffs

May’s jobs report showed a labor market that is improving, with payroll growth exceeding expectations and layoffs down sharply from last year. Steady hiring and fewer layoffs should continue to support consumer spending and U.S. economic growth.

Rapports | Macroéconomique

Monthly Checkpoints

Checkpoints is a comprehensive monthly chartbook highlighting major top-of-mind themes that could shape financial markets in the near term. In addition to the broader macroeconomic discussion, Checkpoints delivers detailed views on major asset classes, including global equities, fixed income and real assets.

Infrastructure

3 ways to respond when inflation bites

A surge in energy prices pushed the latest U.S. Consumer Price Index (CPI) reading above forecasts, reinforcing the case that inflation could remain higher for longer. Higher energy prices have also increased market volatility and uncertainty around the path of interest rates.

Chart of the week | Macroéconomique

A broader foundation for earnings growth

Although companies benefiting most directly from AI-related capital spending are the main drivers of higher earnings, strength is no longer confined to that group. Earnings across the broader market remain solid and are expected to grow more than 10% this year and next, suggesting the risk of concentrated market leadership may not be founded.